Hot Topics in Pharmacy: ASHP Advantage: Prioritizing Prickly Pain Policy

This podcast is very relevant to pharmacists who frequently treat patients or interact with patients in pain. Not all pharmacists are intimately familiar with the FDA’s Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS), which is the official comprehensive pain education strategy essential to frontline providers in order to ensure that patients receive and understand the Medication Guides and information regarding safe use of opioid medications.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.